RADNOR, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Middle District of Tennessee against Acadia Healthcare Company, Inc. (“Acadia Healthcare”) (NASDAQ: ACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 18, 2024, inclusive (the “Class Period”) The lead p ...

PHILADELPHIA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) on behalf of purchasers of Acadia securities between February 28, 2020 through October 18, 2024, inclusive (the “Class Period”). Investor Deadline: Investors who purchased or acquired ACADIA securities during the Class Period may, no later than DECEMBER 16, 2024, seek to be appointed as a ...

NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and certain of the Company’s senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. The c ...

SAN DIEGO, Nov. 17, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) publicly traded securities between February 28, 2020 and September 26, 2024, both dates inclusive (the “Class Period”), have until Monday, December 16, 2024 to seek appointment as lead plaintiff of the Acadia Healthcare class action lawsuit. Captioned Kachrodia v. Acadia Healthcare Company, Inc., No. 24-cv-01238 (M.D. Tenn.), the Acadia Health ...

NEW YORK, Nov. 17, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) between February 28, 2020 and October 18, 2024, both dates inclusive (the "Class Period"), of the important December 16, 2024 lead plaintiff deadline in the securities class action first filed by the Firm.So what: If you purchased Acadia Healthcare securities during the Class Period you may be entitled to compensation without payme ...

RADNOR, Pa., Nov. 17, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare") (NASDAQ: ACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 18, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 16, 2024.CONTACT KESSLER TOPAZ MELTZER & CHECK, ...

NEW YORK, Nov. 16, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and certain of the Company’s senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. The c ...

SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Acadia Healthcare Company (NASDAQ: ACHC) is facing securities class-action lawsuits by investors alleging the company misled them about its business practices. The more recent lawsuit filed on October 29, 2024 expanded the Class Period to end on Oct. 18, 2024 after The New York Times reported that the Veterans Affairs Department has opened an investigation into Acadia, news which sent the price of Acadia shares sharply lower on Oct. 18, 2024. Hagens Berman ur ...

NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and certain of the Company’s senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. The c ...

Core Viewpoint - Acadia Healthcare Company, Inc. is facing a class action lawsuit alleging violations of the Securities Exchange Act of 1934, with claims related to misleading statements and unethical practices regarding patient admissions and treatment [1][3][4]. Group 1: Lawsuit Details - The class action lawsuit is titled Kachrodia v. Acadia Healthcare Company, Inc., and covers purchasers of Acadia's publicly traded securities from February 28, 2020, to September 26, 2024 [1]. - Allegations include that Acadia's business model involved holding patients against their will and subjecting them to abuse, while also deceiving insurance providers into covering unnecessary stays [3][4]. - Following a New York Times article revealing these practices, Acadia's stock price dropped over 4% [4]. Group 2: Regulatory Scrutiny - On September 27, 2024, Acadia disclosed receiving a voluntary request for information from the U.S. Attorney's Office and a grand jury subpoena related to its admissions and billing practices, leading to a further stock price decline of over 16% [5]. - The lawsuit indicates that Acadia anticipates additional document requests from the U.S. Securities and Exchange Commission and other government agencies [5]. Group 3: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows investors who purchased Acadia's securities during the class period to seek appointment as lead plaintiff, representing the interests of the class [6]. - The lead plaintiff can choose a law firm to litigate the case, and participation as lead plaintiff does not affect the ability to share in any potential recovery [6]. Group 4: Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud cases, having recovered $6.6 billion for investors in class action cases, significantly more than any other firm in recent years [7].